ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,104Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 993

$998K Total Retail Price of All Prescriptions

Rank: 15 out of 993

691 Patients Receiving at Least One Drug in Part D
81% Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Kansas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 691 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 691 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 1,105 892 124 1 1
FUROSEMIDE 872 752 121 2 7
POTASSIUM CHLORIDE 834 767 126 3 10
SIMVASTATIN 758 652 100 4 2
LISINOPRIL 751 641 116 5 3
HYDROCODONE-ACETAMINOPHEN 635 512 100 S3 6 4
OMEPRAZOLE 535 443 91 7 5
METFORMIN HCL 448 361 63 8 8
METOPROLOL TARTRATE 439 399 58 9 14
CITALOPRAM HBR 409 351 58 10 16
ATORVASTATIN CALCIUM 373 266 52 11 9
AMLODIPINE BESYLATE 360 323 52 12 6
HYDROCHLOROTHIAZIDE 357 331 52 13 12
ALLOPURINOL 346 303 41 14 32
GABAPENTIN 298 258 51 15 13
PRAVASTATIN SODIUM 288 257 54 16 20
ATENOLOL 282 270 35 17 19
LORAZEPAM 274 239 56 B 18 38
CLOPIDOGREL 273 230 42 19 24
WARFARIN SODIUM 261 222 31 20 11
LOSARTAN POTASSIUM 259 254* 45 21 15
NEXIUM 244 178 35 22 36
MELOXICAM 240 193 45 23 22
NAMENDA 228 <11 <11 24 30
AZITHROMYCIN 221 191 161 25 49
LANTUS 206 182 25 26 52
METOPROLOL SUCCINATE 193 173 28 27 17
KLOR-CON 10 185 159 13 28 135
FLUTICASONE PROPIONATE 181 142 55 29 34
QUETIAPINE FUMARATE 169 138 19 A 30 59
CRESTOR 165 160* 22 31 39
ZETIA 164 136 23 32 70
DONEPEZIL HCL 163 150 22 33 31
CARVEDILOL 162 132 23 34 27
SYNTHROID 161 161 23 35 46
TRAMADOL HCL 159 148 39 36 18
CYMBALTA 157 120 15 37 35
SUCRALFATE 157 152* 28 37 129
CEPHALEXIN 152 129 106 39 81
TAMSULOSIN HCL 150 132 21 40 26
AMITRIPTYLINE HCL 142 137* 19 R 41 61
GLIPIZIDE XL 140 119 15 42 203
MONTELUKAST SODIUM 138 80 28 43 53
ESCITALOPRAM OXALATE 138 116 19 43 50
ALENDRONATE SODIUM 135 112 20 45 28
PROAIR HFA 133 92 42 46 51
BYSTOLIC 133 90 12 46 95
CIPROFLOXACIN HCL 130 103 90 48 62
DILTIAZEM 24HR ER 125 120* 18 49 152
OXYBUTYNIN CHLORIDE 123 111 19 50 101
ACETAMINOPHEN-CODEINE 121 107 48 S3 51 164
GLIPIZIDE 119 102 13 52 64
CYCLOBENZAPRINE HCL 119 70 35 R 52 56
DIVALPROEX SODIUM 117 <11 <11 54 84
ROPINIROLE HCL 112 68 17 55 73
AMLODIPINE BESYLATE-BENAZEPRIL 108 96 11 56 97
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 81 16 57 29
SERTRALINE HCL 104 85 18 57 21
ADVAIR DISKUS 103 64 18 59 69
LOVASTATIN 99 99 16 60 48
PREDNISONE 97 54 31 61 37
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 72 72 62 83
FENTANYL 91 86* 23 S2 63 58
PANTOPRAZOLE SODIUM 89 84* 15 64 33
ISOSORBIDE MONONITRATE ER 87 87 11 65 87
ENALAPRIL MALEATE 86 75 14 66 63
KLOR-CON M20 82 49 15 67 66
HYDROXYZINE HCL 81 76* 11 R 68 220
VERAPAMIL ER 80 <11 <11 69 128
CLONIDINE HCL 80 75* 17 69 68
TRIAMTERENE-HCTZ 79 <11 <11 71 54
BENAZEPRIL HCL 78 66 11 72 67
ALPRAZOLAM 76 71* 14 B 73 23
NOVOLOG 76 <11 <11 73 99
RIVASTIGMINE 75 <11 <11 75 232
AMIODARONE HCL 72 72 14 76 163
VALSARTAN-HYDROCHLOROTHIAZIDE 72 <11 <11 76 151
CLONAZEPAM 66 39 11 B 78 55
ZOLPIDEM TARTRATE 66 61* 13 78 25
FENOFIBRATE* 66 <11 <11 78 71
SPIRONOLACTONE 66 47 14 78 47
DIGOXIN 66 <11 <11 78 86
FENOFIBRATE* 65 <11 <11 83 71
GLYBURIDE 64 <11 <11 R 84 105
RISPERIDONE 63 <11 <11 A 85 80
PREMARIN 62 <11 <11 R 86 143
DIOVAN 61 <11 <11 87 74
QUINAPRIL HCL 61 <11 <11 87 168
METOCLOPRAMIDE HCL 61 <11 <11 87 112
GEMFIBROZIL 61 43 13 87 96
ABILIFY 60 <11 <11 A 91 123
SPIRIVA 58 <11 <11 92 78
DOXYCYCLINE HYCLATE 58 32 35 92 147
DIGOX 57 <11 <11 94 90
LEVEMIR 56 <11 <11 95 167
PIOGLITAZONE HCL 56 <11 <11 R 95 89
MECLIZINE HCL 55 50* 22 97 205
MIRTAZAPINE 55 <11 <11 97 42
NIFEDIPINE ER 54 <11 <11 99 169
FINASTERIDE 54 <11 <11 99 91
LOVAZA 53 <11 <11 101 157
TRIAMCINOLONE ACETONIDE 52 36 35 102 120
HUMALOG 52 <11 <11 102 127
OXYBUTYNIN CHLORIDE ER 52 <11 <11 102 126
NITROGLYCERIN PATCH 51 <11 <11 105 166
VYTORIN 50 <11 <11 106 180
PRADAXA 50 <11 <11 106 210
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.